Peptide Initiative

Peptides · Peptide comparison

CJC-1295 with DAC vs CJC-1295 (No DAC)

Long-acting growth hormone releaser that works around the clock to boost your body's natural GH production with just one or two injections per week.

A modified growth hormone-releasing hormone that boosts your body's natural GH pulses for better recovery, deeper sleep, and improved body composition [13] [17].

  • Growth Hormone
  • Growth Hormone

At a glance

Quick comparison

Dose rangeCJC-1295 with DAC2–2 mgCJC-1295 (No DAC)100–100 mcg
FrequencyCJC-1295 with DACTwice weeklyCJC-1295 (No DAC)Once daily
AdministrationCJC-1295 with DACSubcutaneous injectionCJC-1295 (No DAC)Subcutaneous injection
Cycle lengthCJC-1295 with DAC8-12 weeksCJC-1295 (No DAC)8-12 weeks
Onset speedCJC-1295 with DACModerate (1-2 weeks)CJC-1295 (No DAC)Moderate (1-2 weeks)
Evidence levelCJC-1295 with DACModerate human trials (Phase 1-2)CJC-1295 (No DAC)Moderate human trials (Phase 1-2)

Efficacy

Benefit ratings

GH Elevation

CJC-1295 with DAC92%
CJC-1295 (No DAC)No recorded rating

Convenience

CJC-1295 with DAC95%
CJC-1295 (No DAC)No recorded rating

Recovery Support

CJC-1295 with DAC88%
CJC-1295 (No DAC)85%

GH Stimulation

CJC-1295 with DACNo recorded rating
CJC-1295 (No DAC)88%

Sleep Quality

CJC-1295 with DACNo recorded rating
CJC-1295 (No DAC)92%

Technical data

Compound specifications

CJC-1295 with DAC

Molecular formula
C165H269N47O46
Molecular weight
3647.28 g/mol
Half-life
6-8 days
Bioavailability
~100% (subcutaneous)
CAS number
863288-34-0

CJC-1295 (No DAC)

Molecular formula
C152H252N44O42
Molecular weight
3367.9 g/mol
Half-life
30 minutes to 2 hours
Bioavailability
~100% (subcutaneous)
CAS number
863288-34-0

Protocols

Dosing compared

CJC-1295 with DAC

Subcutaneous

  • 1 mg (1000 mcg)Once weekly · 2-4 weeksA starting dose used in practice. The DAC version is long-acting (about a 6-8 day half-life), so weekly dosing keeps growth hormone and IGF-1 raised. In the Phase 1 trial a single dose raised GH for 6+ days and IGF-1 for up to 11 days. [2]
  • 2 mg (2000 mcg)Once weekly (or split twice weekly) · 8-12 weeksThe common maintenance dose, roughly in line with the 30-60 mcg/kg weekly range studied in the Phase 1 trial. [1][2] In the ascending-dose trials, single injections raised mean GH 2- to 10-fold for six or more days and IGF-I 1.5- to 3-fold for 9-11 days; 30 and 60 µg/kg doses were the best tolerated [2].
  • 2 mg per doseTwice weekly · 8-12 weeksA higher total weekly amount split into two doses, used by experienced users; near the top of the 30-60 mcg/kg weekly range from the clinical study. [2]

CJC-1295 (No DAC)

Subcutaneous

  • 100 mcgOnce daily, 30 minutes before bed · 2-4 weeksA common starting dose used in research practice. Because the no-DAC form is short-acting (about 30 minute half-life), it is injected on an empty stomach for the best growth-hormone pulse. [14][15]
  • 100 mcg per dose1-2 times daily · 8-12 weeksThe typical maintenance dose used in practice, often given before bed and/or after fasted exercise. Frequently paired with a GH-releasing peptide.
  • 100 mcg per dose2-3 times daily · 8-12 weeksA higher-frequency plan used by experienced users to mimic natural GH pulses across the day, each dose taken fasted.

Applications

Best suited for

CJC-1295 with DAC

Growth Hormone Optimization
CJC-1295 with DAC excels at providing a sustained, steady elevation of growth hormone levels. Unlike shorter-acting peptides that create brief spikes, the DAC modification keeps GH elevated for days, mimicking a more youthful hormone profile.
Muscle Building and Recovery
By increasing both GH and IGF-1 levels, this peptide supports protein synthesis and muscle repair. Users often notice improved recovery between workouts and better ability to build and maintain lean muscle mass.
Anti-Aging and Longevity
Growth hormone naturally declines with age, contributing to many signs of aging. CJC-1295 with DAC helps restore more youthful GH levels, potentially supporting better skin quality, energy levels, and overall vitality.
Body Composition Improvement
The combination of increased GH and IGF-1 promotes fat metabolism while preserving muscle tissue. Many users experience gradual fat loss, particularly in stubborn areas, while maintaining or building lean mass.
Convenient Weekly Dosing
Unlike peptides requiring daily or twice-daily injections, the extended half-life of CJC-1295 with DAC means just one or two injections per week provide continuous benefits. Ideal for those who want results without daily protocols.

CJC-1295 (No DAC)

Natural Growth Hormone Optimization
Perfect for those wanting to boost their body's own GH production rather than using synthetic growth hormone. Mimics the natural pulsatile release pattern your pituitary uses [2].
Workout Recovery and Muscle Building
Athletes and fitness enthusiasts use it to accelerate recovery between training sessions, support lean muscle development, and reduce body fat over time [17] [18].
Sleep Quality Enhancement
Because GH is naturally released during deep sleep, many users report dramatically improved sleep quality with more vivid dreams and feeling more refreshed upon waking [12] [13].
Anti-Aging and Vitality
As GH levels decline with age, CJC-1295 helps restore more youthful hormone patterns, potentially improving skin quality, energy levels, and overall well-being [16] [17] [20].
Synergistic Peptide Stacking
Designed to work hand-in-hand with GHRPs like Ipamorelin. When combined, these peptides amplify each other's effects for significantly greater GH release than either alone [9].

Safety profile

Side effects

CJC-1295 with DAC

Common

  • Injection site reactions
  • Water retention
  • Flushing
  • Tingling sensation

Uncommon

  • Headaches
  • Fatigue or lethargy
  • Joint discomfort

Serious

  • Carpal tunnel symptoms
  • Blood glucose elevation

CJC-1295 (No DAC)

Common

  • Injection site reactions
  • Flushing or warmth
  • Water retention
  • Increased appetite

Uncommon

  • Tingling or numbness
  • Headache

Serious

  • Allergic reaction

Research status

Safety & evidence

CJC-1295 with DAC

Evidence level
Moderate human trials (Phase 1-2)
FDA status
Research compound
Safety overview
CJC-1295 with DAC was evaluated in Phase 1-2 human clinical trials where it demonstrated a generally favorable safety profile. The most common adverse events were mild injection site reactions including temporary pain, swelling, and redness. No serious adverse events were reported in the published clinical studies. The compound was being developed for HIV-associated lipodystrophy before the program was discontinued.

Contraindications

  • Active cancer or history of malignancy
  • Pregnancy or breastfeeding
  • Pituitary tumors or disorders
  • Diabetic retinopathy
  • Uncontrolled diabetes

CJC-1295 (No DAC)

Evidence level
Moderate human trials (Phase 1-2)
FDA status
Research compound
Safety overview
CJC-1295 without DAC itself has not been evaluated in controlled human clinical trials; expectations about its safety are extrapolated from studies of related GHRH analogs. The most common side effects are mild and include injection site reactions and temporary flushing [19]. Because it stimulates natural GH release rather than providing exogenous GH, it maintains the body's feedback mechanisms [2].

Contraindications

  • Active cancer or history of cancer
  • Pregnancy or breastfeeding
  • Pituitary tumors or disorders
  • Hypersensitivity to GHRH analogs
  • Diabetic retinopathy

Decision guide

Which is right for you?

CJC-1295 with DAC

Choose CJC-1295 with DAC if…

  • Boosting natural growth hormone production
  • Building lean muscle mass
  • Improving body composition
  • Anti-aging and longevity

CJC-1295 (No DAC)

Choose CJC-1295 (No DAC) if…

  • Increasing natural growth hormone levels
  • Building lean muscle mass
  • Improving sleep quality
  • Enhancing workout recovery